[1]
M. A. Al-Kataan and S. D. Al-Shakarchi, “Changes of some Liver Function Tests with Regular and Irregular Desferroxamine Therapy in β-Thalassemic Patients”, Zanco J Med Sci, vol. 14, no. 1 Special, pp. 166–169, Nov. 2018.